Invesco Ltd.
Invesco Ltd. Fundamental Analysis
Invesco Ltd. (IVZ) shows moderate financial fundamentals with a PE ratio of -40.94, profit margin of -4.42%, and ROE of -2.06%. The company generates $6.3B in annual revenue with moderate year-over-year growth of 6.13%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 27.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IVZ's fundamental strength across five key dimensions:
Efficiency Score
WeakIVZ struggles to generate sufficient returns from assets.
Valuation Score
ExcellentIVZ trades at attractive valuation levels.
Growth Score
ModerateIVZ shows steady but slowing expansion.
Financial Health Score
ExcellentIVZ maintains a strong and stable balance sheet.
Profitability Score
WeakIVZ struggles to sustain strong margins.
Key Financial Metrics
Is IVZ Expensive or Cheap?
P/E Ratio
IVZ trades at -40.94 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, IVZ's PEG of 0.17 indicates potential undervaluation.
Price to Book
The market values Invesco Ltd. at 0.94 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.33 times EBITDA. This is generally considered low.
How Well Does IVZ Make Money?
Net Profit Margin
For every $100 in sales, Invesco Ltd. keeps $-4.42 as profit after all expenses.
Operating Margin
Core operations generate -10.91 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-2.06 in profit for every $100 of shareholder equity.
ROA
Invesco Ltd. generates $-1.04 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Invesco Ltd. produces operating cash flow of $1.50B, showing steady but balanced cash generation.
Free Cash Flow
Invesco Ltd. generates strong free cash flow of $1.54B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $3.46 in free cash annually.
FCF Yield
IVZ converts 13.73% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-40.94
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.17
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.94
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.78
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.83
vs 25 benchmark
Current Ratio
Current assets to current liabilities
43.01
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.02
vs 25 benchmark
ROA
Return on assets percentage
-0.01
vs 25 benchmark
ROCE
Return on capital employed
-0.03
vs 25 benchmark
How IVZ Stacks Against Its Sector Peers
| Metric | IVZ Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -40.94 | 19.02 | Better (Cheaper) |
| ROE | -2.06% | 814.00% | Weak |
| Net Margin | -4.42% | 1811.00% | Weak |
| Debt/Equity | 0.83 | 0.98 | Neutral |
| Current Ratio | 43.01 | 670.41 | Strong Liquidity |
| ROA | -1.04% | -24626.00% (disorted) | Weak |
IVZ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Invesco Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-4.99%
Industry Style: Value, Dividend, Cyclical
DecliningEPS CAGR
7.84%
Industry Style: Value, Dividend, Cyclical
GrowingFCF CAGR
2.10%
Industry Style: Value, Dividend, Cyclical
Growing